Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 6, 2008, Pages 2557-2562

  Vaajanen, Anu ^a   Vapaatalo, Heikki ^a   Kautiainen, Hannu ^b   Oksala, Olli ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^c Research and Development Division   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; OLMESARTAN; 7 ALA ANGIOTENSIN (1 7); 7-ALA-ANGIOTENSIN (1-7); ANGIOTENSIN I; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; OLIGOPEPTIDE; PEPTIDE FRAGMENT; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TOPICAL ANESTHESIA; TOPICAL TREATMENT; ANIMAL; DOSE RESPONSE; DRUG POTENTIATION; INJECTION; OCULOPLETHYSMOGRAPHY; SECRETION; TOPICAL DRUG ADMINISTRATION; VITREOUS BODY;

ADMINISTRATION, TOPICAL; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; AQUEOUS HUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; INJECTIONS; INTRAOCULAR PRESSURE; MALE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PYRIDINES; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 2; TONOMETRY, OCULAR; VITREOUS BODY;

EID: 41949096903     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1399     Document Type: Article

References (47)

1. Wolff G. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms (in French). Nephrologie. 1998;19:451-456. (Pubitemid 28547242)
2. Luft FC. Workshop: mechanism and cardiovascular damage in hypertension. Hypertension. 2001;37:594-598.
3. Ruiz-Ortega M, Lorenzo O, Ruberez M, et al. Role of the reninangiotensin system in vascular diseases: expanding the field. Hypertension. 2001;38:1382-1387. (Pubitemid 34033420)
4. Danser AHJ, Derkx FHM, Admiraal PJJ, Deinum J, de Jong PTVM, Schalekamp MADH. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci. 1994;35:1008-1018. (Pubitemid 24079832)
5. Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci USA. 1986;83:7552-7556. (Pubitemid 16000561)
6. Derkx FH, Alberda AT, Zeilmaker GH, Schalekamp MA. High concentrations of immunoreactive renin, prorenin and enzymaticallyactive renin in human ovarian follicular fluid. Br J Obstet Gynaecol. 1987;94:4-9. (Pubitemid 17027521)
7. Sramek SJ, Wallow IHL, Tewksbury DA, Brandt CR, Poulsen GL. An ocular renin-angiotensin system; immunohistochemistry of angiotensinogen. Invest Ophthalmol Vis Sci. 1992;33:1627-1632.
8. Wagner J, Danser JAH, Derkx FH, et al. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol. 1996;80:159-163. (Pubitemid 26058551)
9. Savaskan E, Loffler KU, Meier F, Muller-Spahn F, Flammer J, Meyer P. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Res. 2004;36:312-320. (Pubitemid 40069656)
10. Hoy Y, Delamere NA. Influence of ANG II on cytoplasmic sodium in cultured rabbit nonpigmented ciliary epithelium. Am J Physiol. 2002;283:C552-C559. (Pubitemid 34787538)
11. Culliane AB, Leung PS, Ortgo J, Coca-Prados M, Harvey BJ. Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium. Br J Ophthalmol. 2002;86:676-683. (Pubitemid 34627960)
12. Lin C, Stone RA, Wax MB. Angiotensin binding sites in rabbit anterior uvea and human ciliary epithelial cells. Invest Ophthalmol Vis Sci. 1990;31:147-152. (Pubitemid 20042473)
13. Shen F, Zhang L, Liu T. Effects of angiotensin II on the 3H-TdR incorporation and synthesis of collagen in cultured bovine trabecular meshwork cells (abstract) (in Chinese). Yan Ke Xue Bao. 2001;17:209-212.
14. Hirsch AT, Pinto YM, Schunkert H, Dzau VJ. Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol. 1990;66:22D-30D. (Pubitemid 20352291)
15. Schelling P, Ganten U, Sponer G, Unger T, Ganten D. Components of the renin angiotensin system in cerebrospinal fluid of rats and dogs with special consideration of the origin and fate of angiotensin II. Neuroendocrinology. 1980;31:297-308. (Pubitemid 10029119)
16. Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol. 1979;23:279-296. (Pubitemid 9168420)
17. Danser AHJ, van der Dorpel MA, Deinum J, et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab. 1989;68:160-167. (Pubitemid 19028740)
18. Constad WH, Fiore P, Samson C, Cinotti AA. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol. 1988;105:674-677. (Pubitemid 18166325)
19. Wang RF, Podos SM, Mittag TW, Yokoyoma T. Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes. Exp Eye Res. 2005;80:629-632. (Pubitemid 40602963)
20. Ueda S, Masumori-Maemoto S, Wada A, Ishii M, Broshinan KB, Umemura S. Angiotensin (1-7) potentiates bradykinin-induced vasodilatation in man. J Hypertens. 2001;19:2001-2009.
21. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension. 1998;31:699-705. (Pubitemid 28086958)
22. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension. 1998;31:356-361. (Pubitemid 28124741)
23. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24,11. Life Sci. 1993;52:1461-1481. (Pubitemid 23103732)
24. Kramkowski K, Mogielnicki A, Buczko W. The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol. 2006;57:529-539. (Pubitemid 46096103)
25. Carey RM, Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal function. Endocr Rev. 2003;24:261-271. (Pubitemid 36733542)
26. Santos RA, Simoes e Silva AC, Maric C, et al. Angiotensin (1-7) is an endogenous ligand for the G-protein-coupled receptor Mas. Proc Natl Acad Sci USA. 2003;8:8258-8263.
27. Iwata M, Cowling RT, Gurantz D, et al. Angiotensin (1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol. 2005;289:H2356-H2363. (Pubitemid 41698543)
28. Kostenis E, Milligan G, Christopoulos A, et al. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type I receptor. Circulation. 2005;111:1806-1813. (Pubitemid 40525146)
29. Mizoue S, Iwai M, Ide A, et al. Role of angiotensin II receptor subtypes in conjunctival wound healing. Curr Eye Res. 2006;31:129-136. (Pubitemid 43315881)
30. Kakar SS, Sellers JS, Devor DC, Musgrove LC, Neill JD. Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem Biophys Res Commun. 1992;183:1090-1096.
31. Hashizume K, Mashima Y, Fumayama, et al. Genetic polymorphisms in the angiotensin II receptor gene and their association with open-angle glaucoma in a Japanese population. Invest Ophthalmol Vis Sci. 2005;46:1993-2001.
32. Bárány EH. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol Vis Sci. 1964;3:135-143.
33. Kotikoski H, Vapaatalo H, Oksala O. Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits. Curr Eye Res. 2003;26:119-123. (Pubitemid 36776119)
34. Alajuuma P, Oksala O, Alaranta S, Palkama A, Uusitalo H. Effect of simultaneous CGRP and PGF(2alpha) on the outflow facility in the rabbit eye. Ophthalmic Res. 2002;34:309-313. (Pubitemid 36151333)
35. Oksala O, Heino P, Uusitalo H, Palkama A. Effect of intracameral and intravitreal injection of calcitonin gene-related peptide on the intraocular pressure and outflow facility of aqueous humor in the rabbit. Exp Eye Res. 1998;67:411-415. (Pubitemid 28552962)
36. Oksala O, Stjernschantz J. Increase in outflow facility of aqueous humor in cats induced by calcitonin gene-related peptide. Exp Eye Res. 1988;47:787-790. (Pubitemid 18272444)
37. Santos RAS, Campagnole-Santos MJ, Andrade SP. Angiotensin (1-7): an update. Regul Peptides. 2000;91:45-62.
38. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27:523-528.
39. Muthalif MM, Benter IF, Uddin MR, Harper JL, Malik KU. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharmacol Exp Ther. 1998;284:388-398. (Pubitemid 28109570)
40. Shah GB, Sharma S, Mehta AA, Goyal RK. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol. 2000;36:169-175. (Pubitemid 30659836)
41. Inoue T, Yokoyoma T, Mori Y, et al. The effect of topical CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits. Curr Eye Res. 2001;23:133-138. (Pubitemid 34499636)
42. Costagliola C, Verolino M, de Rosa ML, Iaccarino G, Ciancaglini M, Mastropasqua L. Effect of oral losartan potassium on intraocular pressure in normotensive and glaucomatous human subjects. Exp Eye Res. 2000;71:167-171.
43. Palm DE, Shue SG, Keil LC, Balaban CD, Severs WB. Effects of angiotensin, vasopressin and atrial natriuretic peptide on intraocular pressure in anesthetized rats. Neuropeptides. 1995;29:193-203.
44. Kaufman PL, Barany EH. Adrenergic drug effects on aqueous outflow facility following ciliary muscle retrodisplacement in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1981;20:644-651. (Pubitemid 11060118)
45. Inoue T, Yokoyoma T, Koike H. The effect of angiotensin II on uveoscleral outflow in rabbits. Curr Eye Res. 2001;23:139-143. (Pubitemid 34499637)
46. Ramirez M, Davidson EA, Luttenauer L, et al. The renin-angiotensin system in the rabbit eye. J Ocul Pharmacol Ther. 1996;12:299-312. (Pubitemid 26335449)
47. Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension. 1998;31:362-367. (Pubitemid 28124742)